Allogene Therapeutics (ALLO) Treasury Shares (2018 - 2025)

Allogene Therapeutics (ALLO) has 8 years of Treasury Shares data on file, last reported at $16.5 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 23.86% year-over-year to $16.5 million; the trailing twelve-month figure through Dec 2025 stood at $16.5 million (up 23.86% YoY), and the FY2025 full-year result was $16.5 million, up 23.86% from the prior year.
• Treasury Shares fell to $16.5 million in Q4 2025, from $16.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $16.6 million in Q3 2025 to a low of $3.1 million in Q1 2021.
• A 5-year average of $9.2 million and a median of $9.2 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares surged 146.5% in 2023 and sank 65.39% in 2025, its largest moves.
• Tracing ALLO's Treasury Shares over 5 years: stood at $4.3 million in 2021, then advanced by 28.92% to $5.5 million in 2022, then jumped by 121.73% to $12.2 million in 2023, then rose by 9.55% to $13.3 million in 2024, then rose by 23.86% to $16.5 million in 2025.
• Business Quant data shows ALLO's Treasury Shares at $16.5 million in Q4 2025, $16.6 million in Q3 2025, and $4.7 million in Q2 2025.